1 Followers USX:TECH - Bio-Techne Corporation Bio-Techne Corporation
Sector: Health Care, Industry: Life Sciences Tools & Services
Next Earnings: 3 Nov 2021
Add to Watchlist
   
Add Alert 


Yahoo Finance (Live Price)

USD 486.75    +5.480 (+1.14%)
Show Technical Chart | 1M    3M    6M    1Y    3Y    5Y         

4 Aug 2021


Loading...
Loading...
Loading...

General

CEO: Mr. Charles R. Kummeth

IPO: 1989-02-09

Headquarters: US

Employees: 2,300

Homepage

Description

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.